| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |